metallothionein 3 ; Mus musculus






81 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1417799 Production of a low molecular weight growth inhibitory factor by adenovirus 12-transformed cells. Biochem Biophys Res Commun 1992 Sep 30 1
2 3281939 Purification of a novel growth inhibitory factor for partially differentiated myeloid leukemic cells. J Biol Chem 1988 Apr 15 1
3 7482533 Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient. Toxicol Appl Pharmacol 1995 Nov 3
4 7655347 Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem Int 1995 Jul 6
5 7718580 Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 1995 Apr 11 4
6 8035803 The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol 1994 Aug 1
7 9006971 Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J Neurosci 1997 Feb 15 3
8 9070344 Metallothioneins in brain--the role in physiology and pathology. Toxicol Appl Pharmacol 1997 Feb 1
9 9465274 Ectopic expression of metallothionein-III causes pancreatic acinar cell necrosis in transgenic mice. Toxicol Appl Pharmacol 1998 Jan 1
10 9518655 In cortical cultures of trisomy 16 mouse brain the upregulated metallothionein-I/II fails to respond to H2O2 exposure or glutamate receptor stimulation. Brain Res 1998 Mar 23 4
11 9593981 Stimulatory effects of 4-methylcatechol, dopamine and levodopa on the expression of metallothionein-III (GIF) mRNA in immortalized mouse brain glial cells (VR-2g). Brain Res 1998 May 11 8
12 10087053 Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther 1999 Apr 1
13 10087067 CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J Neurosci 1999 Apr 1 1
14 10098726 Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression. Neurochem Int 1998 Dec 2
15 10614694 Distribution and retention of mercury in metallothionen-null mice after exposure to mercury vapor. Toxicology 1999 Nov 29 2
16 10640628 Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g). Brain Res 2000 Jan 24 16
17 10712606 Characterization of cis-acting elements in the promoter of the mouse metallothionein-3 gene. Activation of gene expression during neuronal differentiation of P19 embryonal carcinoma cells. Eur J Biochem 2000 Mar 2
18 10759303 Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 2000 Apr 3
19 10854270 Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. J Neurochem 2000 Jul 14
20 10966523 Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. Toxicol Sci 2000 Sep 1
21 11182244 Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience 2001 1
22 11860498 Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice. Eur J Neurosci 2001 Dec 1
23 12501661 [Research progress in brain-specific metallothionein-III]. Sheng Li Ke Xue Jin Zhan 1998 Oct 3
24 12671302 Evidence of increased oxidative stress in hippocampal primary cultures of trisomy 16 mouse. Studies on metallothionein-I/II. Restor Neurol Neurosci 1998 Jun 3
25 12949905 Transcription factor activator protein-1 expressed by kainate treatment can bind to the non-coding region of mitochondrial genome in murine hippocampus. J Neurosci Res 2003 Sep 15 1
26 14695776 Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid. World J Gastroenterol 2004 Jan 1
27 15071173 Susceptibility of metallothionein-null mice to the behavioral alterations caused by exposure to mercury vapor at human-relevant concentration. Toxicol Sci 2004 Jul 1
28 15138662 Mercury accumulation and its distribution to metallothionein in mouse brain after sub-chronic pulse exposure to mercury vapor. Arch Toxicol 2004 Sep 2
29 15157811 Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res 2004 Jun 18 2
30 15196976 Effects of steroid hormones on the Zn, Cu and MTI/II levels in the mouse brain. Brain Res 2004 Jul 2 1
31 15254729 Metallothionein (I/II) suppresses genotoxicity caused by dimethylarsinic acid. Int J Oncol 2004 Aug 1
32 15359896 [Toxicological significance of metallothionein on environmental harmful factors: verification and suggestions from a metallothionein-I/II null mouse model study]. Nihon Eiseigaku Zasshi 2004 Jul 5
33 15581627 Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. FEBS Lett 2004 Dec 3 2
34 15782327 Metal components analysis of metallothionein-III in the brain sections of metallothionein-I and metallothionein-II null mice exposed to mercury vapor with HPLC/ICP-MS. Anal Bioanal Chem 2005 Apr 8
35 16085208 Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A(2). Toxicon 2005 Oct 3
36 16323040 The properties of the metal-thiolate clusters in recombinant mouse metallothionein-4. Protein J 2005 Aug 2
37 16340042 Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes--an in vitro study. J Physiol Pharmacol 2005 Dec 1
38 16640552 Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J 2006 May 1
39 16904082 The effect of Zn(II) and streptozotocin administration in the mouse brain. Brain Res 2006 Sep 13 1
40 16982123 Effects of perinatal exposure to low doses of cadmium or methylmercury on thyroid hormone metabolism in metallothionein-deficient mouse neonates. Toxicology 2006 Nov 10 2
41 17409701 [Analysis of toxicity using metallothionein knockout mice]. Yakugaku Zasshi 2007 Apr 3
42 17435258 Different patterns in the induction of metallothionein mRNA synthesis among isoforms after acute ethanol administration. Biol Trace Elem Res 2007 Feb 2
43 17762829 [Melatonin binding site MT3 is QR2: state of the art]. J Soc Biol 2007 2
44 18295594 Metallothionein-III induces HIF-1alpha-mediated VEGF expression in brain endothelial cells. Biochem Biophys Res Commun 2008 May 2 4
45 18349697 Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment. Psychiatr Genet 2008 Apr 2
46 19027759 Nicotinic and muscarinic cholinergic receptors coexist on GABAergic nerve endings in the mouse striatum and interact in modulating GABA release. Neuropharmacology 2009 Mar 3
47 19254786 Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth. Bone 2009 Jun 3
48 19334502 [Neuroreceptor mechanisms of the afobazole effect]. Eksp Klin Farmakol 2009 Jan-Feb 1
49 19801850 Effects of pergolide mesilate on metallothionein mRNAs expression in a mouse model for Parkinson disease. Biol Pharm Bull 2009 Oct 2
50 20371971 Resistance of metallothionein-III null mice to cadmium-induced acute hepatotoxicity. J Toxicol Sci 2010 Apr 3